The Hydroxyurea Clinic at Nationwide Children's Hospital follows children with sickle cell disease who take hydroxyurea, the only disease modifying medication for sickle cell disease. This medication is effective in reducing the frequency of pain crises, acute chest syndrome episodes, the frequency of blood transfusions and the need for hospitalization, which are common complications of sickle cell disease.
The clinic is staffed by Drs. Susan Creary, MD, Anthony Villella, MD and Jennifer Young, a Certified Nurse Practitioner. During their clinic visit, the pediatric patient is seen by a physician or nurse practitioner, has their labs checked, undergoes a physical examination, and is asked questions about potential side effects from this therapy.